413 related articles for article (PubMed ID: 8842399)
1. Dopaminergic transplants suppress L-DOPA-induced Fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease.
Ishida Y; Kuwahara I; Todaka K; Hashiguchi H; Nishimori T; Mitsuyama Y
Brain Res; 1996 Jul; 727(1-2):205-11. PubMed ID: 8842399
[TBL] [Abstract][Full Text] [Related]
2. Methamphetamine induces fos expression in the striatum and the substantia nigra pars reticulata in a rat model of Parkinson's disease.
Ishida Y; Todaka K; Kuwahara I; Ishizuka Y; Hashiguchi H; Nishimori T; Mitsuyama Y
Brain Res; 1998 Oct; 809(1):107-14. PubMed ID: 9795171
[TBL] [Abstract][Full Text] [Related]
3. Dopaminergic transplants normalize amphetamine- and apomorphine-induced Fos expression in the 6-hydroxydopamine-lesioned striatum.
Cenci MA; Kalén P; Mandel RJ; Wictorin K; Björklund A
Neuroscience; 1992; 46(4):943-57. PubMed ID: 1347413
[TBL] [Abstract][Full Text] [Related]
4. Dopamine metabolism in the striatum of hemiparkinsonian model rats with dopaminergic grafts.
Hashitani T; Mizukawa K; Kumazaki M; Nishino H
Neurosci Res; 1998 Jan; 30(1):43-52. PubMed ID: 9572579
[TBL] [Abstract][Full Text] [Related]
5. Cellular distribution of the NMDA receptor subunit NMDAR1 in fetal ventral mesencephalon transplants in the dopamine-depleted striatum of a rat.
Todaka K; Ishida Y; Hashiguchi H; Nishimori T; Mitsuyama Y
Exp Neurol; 1999 Dec; 160(2):394-401. PubMed ID: 10619556
[TBL] [Abstract][Full Text] [Related]
6. Levodopa induction of Fos immunoreactivity in rat brain following partial and complete lesions of the substantia nigra.
Cole DG; Growdon JH; DiFiglia M
Exp Neurol; 1993 Apr; 120(2):223-32. PubMed ID: 8491280
[TBL] [Abstract][Full Text] [Related]
7. Changes in the regional and compartmental distribution of FosB- and JunB-like immunoreactivity induced in the dopamine-denervated rat striatum by acute or chronic L-dopa treatment.
Cenci MA; Tranberg A; Andersson M; Hilbertson A
Neuroscience; 1999; 94(2):515-27. PubMed ID: 10579213
[TBL] [Abstract][Full Text] [Related]
8. Intranigral ventral mesencephalic grafts and nigrostriatal injections of glial cell line-derived neurotrophic factor restore dopamine release in the striatum of 6-hydroxydopamine-lesioned rats.
Tang FI; Tien LT; Zhou FC; Hoffer BJ; Wang Y
Exp Brain Res; 1998 Apr; 119(3):287-96. PubMed ID: 9551829
[TBL] [Abstract][Full Text] [Related]
9. Fetal ventral mesencephalic grafts functionally reduce the dopamine D2 receptor supersensitivity in partially dopamine reinnervated host striatum.
Strömberg I; Kehr J; Andbjer B; Fuxe K
Exp Neurol; 2000 Jul; 164(1):154-65. PubMed ID: 10877926
[TBL] [Abstract][Full Text] [Related]
10. Dopaminergic transplants alter in vivo activity of tryptophan hydroxylase in the striatum in a rat model of Parkinson's disease.
Ishida Y; Hashiguchi H; Todaka K; Kuwahara I; Mitsuyama Y
Neurosci Lett; 1996 May; 210(2):75-8. PubMed ID: 8783276
[TBL] [Abstract][Full Text] [Related]
11. Dopaminergic microtransplants into the substantia nigra of neonatal rats with bilateral 6-OHDA lesions. I. Evidence for anatomical reconstruction of the nigrostriatal pathway.
Nikkhah G; Cunningham MG; Cenci MA; McKay RD; Björklund A
J Neurosci; 1995 May; 15(5 Pt 1):3548-61. PubMed ID: 7538563
[TBL] [Abstract][Full Text] [Related]
12. Restoration of complex sensorimotor behavior and skilled forelimb use by a modified nigral cell suspension transplantation approach in the rat Parkinson model.
Nikkhah G; Duan WM; Knappe U; Jödicke A; Björklund A
Neuroscience; 1993 Sep; 56(1):33-43. PubMed ID: 8232915
[TBL] [Abstract][Full Text] [Related]
13. L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of parkinson's disease: relation to motor and cellular parameters of nigrostriatal function.
Winkler C; Kirik D; Björklund A; Cenci MA
Neurobiol Dis; 2002 Jul; 10(2):165-86. PubMed ID: 12127155
[TBL] [Abstract][Full Text] [Related]
14. The effect of chronic L-dopa treatment on the recovery of motor function in 6-hydroxydopamine-lesioned rats receiving ventral mesencephalic grafts.
Blunt S; Jenner P; Marsden CD
Neuroscience; 1991; 40(2):453-64. PubMed ID: 1902916
[TBL] [Abstract][Full Text] [Related]
15. Aromatic L-amino acid decarboxylase immunoreactive cells in the rat striatum: a possible site for the conversion of exogenous L-DOPA to dopamine.
Mura A; Jackson D; Manley MS; Young SJ; Groves PM
Brain Res; 1995 Dec; 704(1):51-60. PubMed ID: 8750961
[TBL] [Abstract][Full Text] [Related]
16. Motor function, graft survival and gliosis in rats with 6-OHDA lesions and foetal ventral mesencephalic grafts chronically treated with L-dopa and carbidopa.
Blunt SB; Jenner P; Marsden CD
Exp Brain Res; 1992; 88(2):326-40. PubMed ID: 1577107
[TBL] [Abstract][Full Text] [Related]
17. Autoradiographic study of striatal D1 and D2 dopamine receptors in 6-OHDA-lesioned rats receiving foetal ventral mesencephalic grafts and chronic treatment with L-dopa and carbidopa.
Blunt SB; Jenner P; Marsden CD
Brain Res; 1992 Jun; 582(2):299-311. PubMed ID: 1393551
[TBL] [Abstract][Full Text] [Related]
18. Blockade of N-methyl-D-aspartate receptors potentiates dopaminergic responses in the 6-OHDA model of Parkinson: differential role of D-1 and D-2 receptors.
Morelli M; Fenu S; Di Chiara G
Neurochem Int; 1992 Mar; 20 Suppl():261S-264S. PubMed ID: 1365438
[TBL] [Abstract][Full Text] [Related]
19. A 6-hydroxydopamine-induced selective parkinsonian rat model: further biochemical and behavioral characterization.
Thomas J; Wang J; Takubo H; Sheng J; de Jesus S; Bankiewicz KS
Exp Neurol; 1994 Apr; 126(2):159-67. PubMed ID: 7925817
[TBL] [Abstract][Full Text] [Related]
20. cAMP response element-binding protein is required for dopamine-dependent gene expression in the intact but not the dopamine-denervated striatum.
Andersson M; Konradi C; Cenci MA
J Neurosci; 2001 Dec; 21(24):9930-43. PubMed ID: 11739600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
